Legend Biotech (LEGN) is a publicly traded Healthcare sector company. As of October 23, 2026, LEGN trades at $18.73 with a market cap of $3.62B and a P/E ratio of 0.00. LEGN moved +1.50% today. Year to date, LEGN is -6.94%; over the trailing twelve months it is -41.14%. Its 52-week range spans $16.24 to $45.30. Analyst consensus is buy with an average price target of $44.01. Rallies surfaces LEGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks LEGN insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $18.73 |
| Market Cap | $3.62B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $45.30 |
| 52-Week Low | $16.24 |
| Volume | 1.08M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
9 analysts cover LEGN: 0 strong buy, 5 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $44.01.